New study checks if HIV prevention shots and contraceptives clash

NCT ID NCT07516548

First seen Apr 14, 2026 · Last updated May 16, 2026 · Updated 4 times

Summary

This study looks at how a long-acting injectable HIV prevention drug (CAB-LA) and hormonal birth control methods (like the shot or implant) affect each other in women. About 105 women who are already using CAB-LA or not using PrEP will join groups based on their birth control choice. Researchers will take blood samples over 12 to 24 weeks to measure drug and hormone levels, and check for side effects. The goal is to understand if using both together changes how well either one works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Princess Marina Hospital

    Bontleng, Gaborone, Botswana

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.